U-Blot® Research Grade Anti-Human CFB Antibody (SAR-443809)Cat. No. WA1816Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CFB Antibody (SAR-443809)Cat. No. WA1816
U-Blot® Research Grade Anti-Human CEACAM7 Antibody (2869#)Cat. No. WA1815
U-Blot® Research Grade Anti-Human CEA & CD3 Bispecific Antibody (MEDI-565)Cat. No. WA1814
U-Blot® Research Grade Anti-Human CDH6/Cadherin-6 Antibody (H01L02)Cat. No. WA1813
U-Blot® Research Grade Anti-Human CDH6/Cadherin-6 (HKT288)Cat. No. WA1812
U-Blot® Research Grade Anti-Human CDH6 (DS-6000a)Cat. No. WA1811
U-Blot® Research Grade Anti-Human CDH3/P-cadherin (PF-03732010)Cat. No. WA1810
U-Blot® Research Grade Anti-Human CDH3/P-cadherin (PCA062)Cat. No. WA1809
U-Blot® Research Grade Anti-Human CDH3/P-cadherin (FF-21101)Cat. No. WA1808
U-Blot® Research Grade Anti-Human CDH3/P-cadherin & CD3E Antibody (PF 6671008)Cat. No. WA1807
U-Blot® Research Grade Anti-Human CDH17/Cadherin-17 Antibody (PTA001_A4)Cat. No. WA1806
U-Blot® Research Grade Anti-Human CDH11 Antibody (RG6125)Cat. No. WA1805